Neoantigen-based peptide vaccine
Sponsors
The First Affiliated Hospital of Nanchang University
Conditions
Advanced NSCLCColorectal Cancer (CRC)
Phase 2
Unknown Phase
Neoantigen-based Peptide Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
RecruitingNCT06751914
Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30
Neoantigen-based Peptide Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
RecruitingNCT06752044
Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
RecruitingNCT06751966
Start: 2024-09-01End: 2027-02-28Target: 10Updated: 2024-12-30